Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alcon Ord Shs ALC

Healthcare Medical Instruments & Supplies
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes... see more

Recent & Breaking News (NYSE:ALC)

Alcon Launches TOTAL30 Multifocal Contact Lenses for Patients with Presbyopia

Business Wire October 10, 2023

Cataract Surgery with Alcon's AcrySof IQ Vivity IOLs Demonstrates Sustained High Patient Satisfaction and Reduced Spectacle Dependence

Business Wire September 9, 2023

Alcon Announces its Largest-Ever Scientific Program at the 41st Congress of the ESCRS, Showcasing New Data and Innovation to Support Ophthalmic Surgical Teams

Business Wire September 6, 2023

Alcon Reports Second Quarter 2023 Results

Business Wire August 15, 2023

Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer

GlobeNewswire May 22, 2023

Alcon Advances Company's Social Impact Through Global Volunteerism

Business Wire May 22, 2023

Alcon Reports First Quarter 2023 Results

Business Wire May 9, 2023

New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision

Business Wire May 6, 2023

Alcon Announces Results of 2023 Annual General Meeting

Business Wire May 5, 2023

Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity

Business Wire May 1, 2023

Alcon Publishes Agenda for 2023 Annual General Meeting

Business Wire March 29, 2023

Alcon's "The Lens" Interactive Compliance Training Experience Receives Coveted Anthem Award

Business Wire March 23, 2023

Alcon to Host 2023 Capital Markets Day

Business Wire March 20, 2023

Alcon to Debut TOTAL30 for Astigmatism, Dry Eye and Ocular Health Innovations at SECO 2023

Business Wire March 1, 2023

Alcon Reports Fourth Quarter and Full Year 2022 Results

Business Wire February 27, 2023

Alcon Announces Settlement of Litigation Related to Femtosecond Laser Assisted Cataract Surgery Devices

Business Wire February 12, 2023

Alcon Canada launches new TOTAL toric lenses for astigmatic patients

Business Wire February 2, 2023

Alcon Introduces a Premium, Reusable Toric Lens with Launch of TOTAL30 for Astigmatism

Business Wire January 5, 2023

Alcon to Present at 2023 Annual J.P. Morgan Healthcare Conference

Business Wire December 28, 2022

Alcon Prices US$1.3 Billion Senior Notes Offering

Business Wire November 29, 2022